⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SPRY
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Issues Important Reminder to ARS Pharmaceuticals, Inc. Shareholders – SPRY
accessnewswire.com
SPRY
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
Pomerantz LLP Issues Important Reminder to ARS Pharmaceuticals, Inc. Investors – SPRY
accessnewswire.com
SPRY
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 – Contact Levi & Korsinsky
accessnewswire.com
SPRY
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action – Contact Levi & Korsinsky
accessnewswire.com
SPRY
Pomerantz LLP Issues Important Reminder to ARS Pharmaceuticals, Inc. Investors – SPRY
accessnewswire.com
SPRY
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities Violations – Contact Levi & Korsinsky Today
accessnewswire.com
SPRY